Bosentan Orally Disintegrating Tablets(Beijing Sunho Pharma)

波生坦口崩片（北京星昊医药）

Report date: 2025/09/23 09:57:00

Base Information

Drug NameBosentan Orally Disintegrating Tablets(Beijing Sunho Pharma)
Drug Alias NameBosentanum波生坦水合物波生坦一水合物波生坦口崩片（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonistsEndothelin receptor type A antagonists
TargetsEndothelin receptor type AEndothelin receptor type B
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Sunho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Sunho Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG